Tue, 19 Feb 2019 | ADMINISTRATION
A pharmaceutical manufacturing company based in Bristol has entered administration after experiencing a series of financial difficulties.
Avara Avlon Pharma Services Limited called in administrators after a major contract came to an end, raising questions regarding the future of the company.
Accounting firm David Rubin & Partners were called in to oversee the administration process, with partners David Rubin and Asher Miller appointed at the High Court of Justice as joint administrators.
Rubin commented on the administration: "Avlon has experienced financial difficulties in recent months as a result of a major contract with a customer coming to an end. The joint administrators are now managing the site, whilst they seek a buyer for the business and assets.
"The main issues here are keeping the site operational and ensuring that all health, safety and environment obligations are complied with. We are working closely with the highly professional and experienced workforce to do everything we can to obtain the best outcome for all stakeholders.
"We have already secured an agreement with the major customer that gives the business immediate short-term funding and means that we do not immediately have to consider mass redundancies.”
Presently, Avara Avlon Pharma Services employs roughly 270 members of staff at its 100-acre site in Avonmouth to manufacture a number of active pharmaceutical ingredients. As well as in the UK, the company also has operational sites in Ireland, US, Canada and France.
The premise was previously acquired from AstraZeneca in 2016, which is one of Avara Avlon Pharma Services’ primary customers.
Potential buyers of Avara Avlon Pharma Services Limited’s business and assets are invited to express their interest immediately.
For more news stories about administrations click here. For all our administrations listings, click here.
This business was originally established in 1990 by our clients; who are now looking to sell the business due to the desire to take a well-deserved retirement. The business runs as a residential care home which specialises in Dementia and Alzheimer’s...
FREEHOLD
Strategically sources commercial pharmaceutical medicines for all stages of clinical trials, supplying blue-chip clients on a global scale. Fully licenced to supply pharmaceuticals within the US – the largest single market for clinical trials globall...
FREEHOLD
Specialist care agency, focusing on supportive living for young people aged 16-18. Established 14+ years ago and based in the UK, our client works solely with local authorities providing housing and support for young, vulnerable people. Each vulnerab...
|
19
|
|
Nov
|
UK government set to approve Cobham takeover | BUSINESS SALE
The British government is poised to approve the $5 billion t...
|
18
|
|
Nov
|
Kitwave acquires Alpine Fine Foods | BUSINESS SALE
Independent wholesaler Kitwave has acquired Alpine Fine Food...
|
15
|
|
Nov
|
Carpetright agrees to shareholder takeover deal | BUSINESS SALE
Carpetright has agreed a deal to be taken over by its larges...
Sign up to receive our acquisition alert emails to get your FREE guide
|
20
|
|
Dec
|
AR tech company enters administration | ADMINISTRATION
An augmented reality technology enterprise, whose technology...
|
29
|
|
Oct
|
Drugs company sold to AstraZeneca | BUSINESS SALE
A drugs company that specialises in anti-cancer medication h...
Business Sale Report is your complete solution to finding great acquisition opportunities.
Join today to receive:
All this and much more, including the latest M&A news and exclusive resources